DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Oza AM, Townsley CA, Siu LL. et al.
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer.
Proc Am Soc Clin Oncol 2003; 22: 196a-
We do not assume any responsibility for the contents of the web pages of other providers.